Commonly reported side effects may include: Mild abdominal cramping Bloating or increased flatulence Loose stools In very rare cases, some individuals may experience a skin rash or sensitivity
Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids
hdl:1765/32655

Key Points Native human GLP-1 normalizes hyperglycaemia in patients with type 2 diabetes mellitus, but the short in vivo half-life of this hormone limits its therapeutic application A number of synthetic GLP-1 receptor agonists, with half-lives between 23 h and several days, have been developed for the long-term treatment of type 2 diabetes mellitus Short-acting GLP-1 receptor agonists (such as exenatide and lixisenatide) predominantly lower postprandial glucose levels and insulin concentrations via retardation of gastric emptying Long-acting GLP-1 receptor agonists (such as albiglutide, dulaglutide, exenatide long-acting release and liraglutide) predominantly lower blood glucose levels through stimulation of insulin secretion and reduction of glucagon levels Adverse effects of GLP-1 receptor agonists include nausea, vomiting and diarrhoea, injection-site reactions, antibody formation and increased heart rate This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access 186,36 per year only 15,53 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Supports antioxidant defenses and detoxification in an innovative liposomal form*
Overnight mask with Vital Vita Solution, a powerhouse complex of derivative Vitamin C, Niacinamide and Panthenol for healthy, hydrated lips